Avive Solutions is a technology company.
Avive Solutions has raised $84.0M across 3 funding rounds.
Avive Solutions has raised $84.0M in total across 3 funding rounds.
Avive Solutions has raised $84.0M in total across 3 funding rounds.
Avive Solutions's investors include Autism Impact Fund, Deerfield Management, Questa Capital, Vitalize Venture Group.
Avive Solutions is a Brisbane, California-based healthcare technology company founded in 2017 that develops the Avive Connect AED®, the smallest, lightest, and first new FDA-approved automated external defibrillator (AED) to enter the U.S. market in nearly 20 years.[1][2][3][5] It serves communities, schools, police departments, cities, and organizations by addressing out-of-hospital cardiac arrest (OHCA)—a leading cause of death with low survival rates—through connected hardware and the REALConnect™ software platform that integrates with 911 systems, provides real-time AED fleet insights, and automates maintenance to boost response times and survivability.[1][2][3][4] The company demonstrates strong growth momentum, including a 2024 NASPO ValuePoint® contract for AEDs (2024-2029), ranking #3 in Fast Company's 2025 Most Innovative Companies (Small and Mighty category), and real-world deployments like saving lives in Forsyth County, GA, Northern KY, and Cumberland County via its 4 Minute Community™ program.[1][2][3][4]
Avive Solutions was co-founded in 2017 by CEO Sameer Jafri, Rory, and Moseley, blending Jafri's experience in sudden cardiac arrest (SCA) prevention from his non-profit Saving Hearts Foundation with Rory and Moseley's technical expertise and novel AED concept developed at MIT.[5] The idea emerged from recognizing the "massive global problem" of SCA, where traditional standalone AEDs fail to integrate into broader response systems, leaving most OHCA cases untreated despite bystander potential.[1][4][5] Early traction built through innovation in connected AEDs, culminating in FDA approval after nearly 20 years without new entrants, and pivotal 2024 launches like QuickRescue™ (direct 911 alerting via RapidSOS partnership) and Intelligent Response™ for dispatcher-led bystander activation.[2][3]
Avive rides the trend of connected health tech and IoT integration in emergency response, transforming passive AEDs into active ecosystem nodes amid rising demand for rapid OHCA intervention—where survival drops 10% per minute without defibrillation.[1][4][5] Timing aligns with post-pandemic focus on public health infrastructure, FDA openness to innovation after two decades, and partnerships like RapidSOS accelerating 911 upgrades.[2][3] Market forces favoring Avive include massive SCA scale (leading U.S. killer outside hospitals), underutilized bystander AEDs, and government contracts like NASPO enabling scalable deployment to schools, cities, and fleets.[1][4] It influences the ecosystem by setting standards for 911-AED connectivity, inspiring "connected communities," and proving tech can humanize life-saving actions, potentially raising national survival rates from ~10%.[2][3][5]
Avive is poised for expansion through national contracts, further 911 integrations, and global SCA markets, leveraging its first-mover connectivity edge to dominate smart AEDs.[1][2][3] Trends like AI-driven response analytics, broader RapidSOS adoption, and public mandates for AEDs in high-risk venues will propel growth, while data from deployments refines REALConnect™ for predictive maintenance.[3][4] Its influence may evolve from innovator to ecosystem leader, partnering with more cities and providers to make "no witnessed SCA untreated" a reality—building on its mission to empower everyday rescuers with tech that turns emergencies into successes.[5]
Avive Solutions has raised $84.0M across 3 funding rounds. Most recently, it raised $57.0M Series B in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $57.0M Series B | Autism Impact Fund, Deerfield Management, Questa Capital | |
| Mar 1, 2022 | $22.0M Series A | Autism Impact Fund, Deerfield Management, Questa Capital | |
| Jun 1, 2019 | $5.0M Series A | Vitalize Venture Group |